Free
protein S rather than total
protein S levels are currently measured to detect inherited
protein S deficiency. Because type III (free
protein S) deficiency is still not established as risk factor for
thrombosis, we assessed the absolute risk of venous and arterial
thromboembolism in a family cohort study. Annual incidences in first-degree relatives with and without
protein S deficiency type III were compared. Probands had experienced
thrombosis and had either the
prothrombin G20210A mutation, increased
factor VIII:C levels or
hyperhomocysteinemia. Relatives were tested for these thrombophilic disorders and
factor V Leiden. Levels of
antithrombin,
protein C, total and free
protein S, and
factor XI:C were additionally measured. Of 500 relatives enrolled, 105 were excluded from analysis because they could not be classified, due to acquired conditions.
Protein S deficiency type III was demonstrated in 60/395 remaining relatives (15%). Other thrombophilic defects were equally distributed among deficient and non-deficient relatives. Annual incidences of
venous thromboembolism were 0.28 per 100 person-years [95% confidence interval (CI), 0.09-0.66] in deficient relatives versus 0.20 per 100 person-years (95% CI, 0.12-0.30) in non-deficient relatives [hazard ratio, 1.4 (95% CI, 0.4-4.0)]. For arterial
thromboembolism these values were 0.16 per 100 person-years (95% CI, 0.03-0.46) versus 0.10 per 100 person-years (95% CI, 0.05-0.19) [hazard ratio, 1.5 (95% CI, 0.3-6.0)]. These results suggest that
protein S deficiency type III is not associated with an increased risk of either venous or arterial
thromboembolism.